Henry James International Management Inc. Decreases Stake in Infosys Limited (NYSE:INFY)

Henry James International Management Inc. lessened its stake in shares of Infosys Limited (NYSE:INFY) by 0.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 107,515 shares of the technology company’s stock after selling 625 shares during the quarter. Henry James International Management Inc.’s holdings in Infosys were worth $2,357,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Infosys by 188.9% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 87,794 shares of the technology company’s stock worth $1,955,000 after buying an additional 57,400 shares during the last quarter. abrdn plc boosted its stake in shares of Infosys by 164.4% in the third quarter. abrdn plc now owns 321,227 shares of the technology company’s stock worth $7,123,000 after acquiring an additional 199,748 shares during the period. First Trust Direct Indexing L.P. lifted its holdings in Infosys by 9.8% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 76,989 shares of the technology company’s stock worth $1,715,000 after purchasing an additional 6,852 shares in the last quarter. Financial Advocates Investment Management boosted its position in shares of Infosys by 5.9% during the third quarter. Financial Advocates Investment Management now owns 22,574 shares of the technology company’s stock worth $503,000 after acquiring an additional 1,262 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Infosys by 39.5% during the 3rd quarter. US Bancorp DE now owns 272,974 shares of the technology company’s stock valued at $6,079,000 after purchasing an additional 77,226 shares during the last quarter. 16.20% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

INFY has been the topic of several research reports. Guggenheim restated a “neutral” rating on shares of Infosys in a research report on Friday, January 17th. StockNews.com raised Infosys from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. HSBC upgraded shares of Infosys from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Finally, Hsbc Global Res raised shares of Infosys from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $20.22.

Infosys Price Performance

Shares of NYSE INFY opened at $20.09 on Friday. Infosys Limited has a 1-year low of $16.04 and a 1-year high of $23.63. The stock has a market capitalization of $83.19 billion, a P/E ratio of 25.42, a price-to-earnings-growth ratio of 3.50 and a beta of 1.00. The business has a fifty day moving average price of $21.88 and a 200 day moving average price of $22.27.

Infosys (NYSE:INFY) last released its quarterly earnings results on Thursday, January 16th. The technology company reported $0.19 EPS for the quarter, meeting analysts’ consensus estimates of $0.19. Infosys had a return on equity of 31.60% and a net margin of 17.28%. During the same period in the previous year, the firm earned $0.18 earnings per share. As a group, equities research analysts anticipate that Infosys Limited will post 0.74 earnings per share for the current fiscal year.

Infosys Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.